Low dietary folate and methylenetetrahydrofolate reductase deficiency may lead to pregnancy complications through modulation of ApoAI and IFN-γ in spleen and placenta, and through reduction of methylation potential

Molecular Nutrition and Food Research

Volumn 57, Issue 4, 2013, Pages 661-670

  Mikael, Leonie G ^a   Pancer, Jill ^a   Jiang, Xinyin ^b   Wu, Qing ^a   Caudill, Marie ^b   Rozen, Rima ^a  

^a RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b Department of Molecular Biology and Genetics   (United States)

Author keywords

ApoAI; Folate; Homocysteine; IFN ; Pregnancy

Indexed keywords

APOLIPOPROTEIN A1; BETAINE; CHOLINE; FOLIC ACID; GAMMA INTERFERON; HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BLOOD; DIET; FEMALE; FOLIC ACID DEFICIENCY; GENETICS; HOMOCYSTINURIA; LIVER; MALE; METABOLISM; METHYLATION; MOUSE; PATHOLOGY; PLACENTA; PREGNANCY; PREGNANCY COMPLICATION; PSYCHOSIS; SPASTICITY; SPLEEN; TRANSGENIC MOUSE;

ANIMALS; APOLIPOPROTEIN A-I; BETAINE; CHOLINE; DIET; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; HOMOCYSTEINE; HOMOCYSTINURIA; INTERFERON-GAMMA; LIVER; MALE; METHYLATION; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; MUSCLE SPASTICITY; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS; PSYCHOTIC DISORDERS; S-ADENOSYLHOMOCYSTEINE; S-ADENOSYLMETHIONINE; SPLEEN;

MUS;

EID: 84875836627     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200152     Document Type: Article

References (63)

1. Schwahn, B. C., Chen, Z., Laryea, M. D., Wenderl, U. et al., Homocysteine-betaine interactions in a murine model of 5, 10-methylenetetrahydrofolate reductase deficiency. FASEB J. 2003, 17, 512-514.
2. Li, D., Pickell, L., Liu, Y., Wu, Q. et al., Maternal methylenetetrahydrofolate reductase deficiency and low dietary folate lead to adverse reproductive outcomes and congenital heart defects in mice. Am. J. Clin. Nutr. 2005, 82, 188-195.
3. Pickell, L., Li, D., Brown, K., Mikael, L. G. et al., Methylenetetrahydrofolate reductase deficiency and low dietary folate increase embryonic delay and placental abnormalities in mice. Birth Defects Res. A Clin. Mol. Teratol. 2009, 85, 531-541.
4. Caudill, M. A., Folate and choline interrelationships: metabolic and potential health implications, in: Bailey L. B. (Ed.), Folate in health and disease, CRC Press, Boca Raton (FL) 2009, pp. 449-465.
5. Chen, Z., Karaplis, A. C., Ackerman, S. L., Pogribny, I. P. et al., Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum. Mol. Genet. 2001, 10, 433-443.
6. Frosst, P., Blom, H. J., Milos, R., Goyette, P. et al., A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 1995, 10, 111-113.
7. Jacques, P. F., Bostom, A. G., Williams, R. R., Ellison, R. C. et al., Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996, 93, 7-9.
8. Eikelboom, J. W., Lonn, E., Genest, J. J., Hankey, G. et al., Homocysteine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann. Int. Med. 1999, 131, 363-375.
9. Dodds, L., Fell, D. B., Dooley, K. C., Armson, B. A. et al., Effect of homocysteine concentration in early pregnancy on gestational hypertensive disorders and other pregnancy outcomes. Clin. Chem. Lab Med. 2008, 54, 326-334.
10. Vollset, S. E., Refsum, H., Irgens, L. M., Emblem, B. M. et al., Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine Study. Am. J. Clin. Nutr. 2000, 71, 962-968.
11. Bryushkova, E. A., Vladychenskaya, E. A., Stepanova, M. S., Boldyrev, A. A., Effect of homocysteine on properties of neutrophils activated in vivo. Biochemistry (Mosc) 2011, 76, 467-472.
12. Lazzerini, P. E., Capecchi, P. L., Selvi, E., Lorenzini, S. et al., Hyperhomocysteinemia, inflammation and autoimmunity. Autoimmun. Rev. 2007, 6, 503-509.
13. Schroecksnadel, K., Frick, B., Winkler, C., Leblhuber, F. et al., Hyperhomocysteinemia and immune activation. Clin. Chem. Lab Med. 2003, 41, 1438-1443.
14. Curry, A. E., Vogel, I., Drews, C., Shcendel, D. et al., Mid-pregnancy maternal plasma levels of interleukin-2, 6, and 12, tumor necrosis factor-alpha, interferon gamma, and granulocyte-macrophage colony-stimulating factor and spontaneous preterm delivery. Acta. Obstet. Gynecol. Scand. 2007, 86, 1103-1110.
15. Fasouliotis, S. J., Spandorfer, S. D., Witkin, S. S., Schattman, G. et al., Maternal serum levels of interferon-gamma and interleukin-2 soluble receptor-alpha predict the outcome of early IVF pregnancies. Hum. Reprod. 2004, 19, 1357-1363.
16. Ahn, H., Park, J., Gilman-Sachs, A., Kwak-Kim, J., Immunologic characteristics of preeclampsia, a comprehensive review. Am. J. Reprod. Immunol. 2011, 65, 377-394.
17. Paulesu, L., Bhattacharjee, J., Bechi, N., Romagnoli, R. et al., Pro-inflammatory cytokines in animal and human gestation. Curr. Pharm. Des. 2010, 16, 3601-3615.
18. Mikael, L. G., Pancer, J., Wu, Q., Rozen, R., Disturbed one-carbon metabolism causing adverse reproductive outcomes in mice is associated with altered expression of ApoAI and inflammatory mediators PPARα, IFN-γ and IL-10. J. Nutr. 2012, 142, 411-418.
19. Havel, R. J., Introduction: structure and metabolism of plasma lipoproteins, in: Scriver C. R., Beaudet A. L., Sly W. S., Valle D. (Eds). The metabolic and molecular bases of inherited disease, McGraw-Hill, New York 1995, pp. 1841-1851.
20. Shah, P. K., Kaul, S., Nilsson, J., Cercek, B., Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming. Circulation 2001, 104, 2376-2383.
21. Morishima, A., Ohkubo, N., Maeda, N., Miki, T. et al., NFκB regulates plasma apolipoprotein AI and high density lipoprotein cholesterol through inhibition of peroxisome proliferator-activated receptor α. J. Biol. Chem. 2003, 278, 38188-38193.
22. Duez, H., Lefebvre, B., Poulain, P., Torra, I. P. et al., Regulation of human apoA-I by gemfibrozil and fenofibrate through selective peroxisome proliferator-activated receptor alpha modulation. Arterioscler. Thromb. Vasc. Biol. 2004, 25, 585-591.
23. Mikael, L. G., Genest, J. J., Rozen, R., Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease. Circ. Res. 2006, 98, 564-571.
24. Mikael, L. G., Wang, X. L., Wu, Q., Jiang, H. et al., Hyperhomocysteinemia is associated with hypertriglyceridemia in mice with methylenetetrahydrofolate reductase deficiency. Mol. Genet. Metab. 2009, 98, 187-194.
25. Holm, P. I., Ueland, P. M., Kvalheim, G., Lien, E. A., Determination of choline, betaine, and dimethylglycine in plasma by a high-throughput method based on normal-phase chromatography-tandem mass spectrometry. Clin. Chem. 2003, 49, 286-294.
26. Koc, H., Mar, M. H., Ranasinghe, A., Swenberg, J. A. et al., Quantitation of choline and its metabolites in tissues and foods by liquid chromatography/electrospray ionization-isotope dilution mass spectrometry. Anal. Chem. 2002, 74, 4734-4740.
27. Chew, T. W., Jiang, X., Yan, J., Wang, W. et al., Folate intake, MTHFR genotype, and sex modulate choline metabolism in mice. J. Nutr. 2011, 141, 1475-1481.
28. Kim, J. K., Harada, K., Bamba, T., Fukusaki, E. et al., Stable isotope dilution-based accurate comparative quantification of nitrogen-containing metabolites in Arabidopsis thaliana T87 cells using in vivo (15)N-isotope enrichment. Biosci. Biotechnol. Biochem. 2005, 69, 1331-1340.
29. Christensen, K. E., Wu, Q., Wang, X. L., Deng, L. et al., Steatosis in mice is associated with gender, folate intake, and expression of genes of one-carbon metabolism. J. Nutr. 2010, 140, 1736-1741.
30. Schoenborn, J. R., Wilson, C. B., Regulation of interferon-gamma during innate and adaptive immune responses. Adv. Immunol. 2007, 96, 41-101.
31. Chan, J., Deng, L., Mikael, L. G., Yan, J. et al., Low dietary choline and low dietary riboflavin during pregnancy influence reproductive outcomes and heart development in mice. Am. J. Clin. Nutr. 2010, 91, 1035-1043.
32. Zeisel, S. H., Blusztajn, J. K., Choline and human nutrition. Annu. Rev. Nutr. 1994, 14, 269-296.
33. Podo, F., Tumour phospholipid metabolism. NMR Biomed. 1999, 12, 413-439.
34. Zeisel, S. H., Wurtman, R. J., Developmental changes in rat blood choline concentration. Biochem. J. 1981, 198, 565-570.
35. Ozarda, I. Y., Uncu, G., Ulus, I. H., Free and phospholipid-bound choline concentrations in serum during pregnancy, after delivery and in newborns. Arch. Physiol. Biochem. 2002, 110, 393-399.
36. Sweiry, J. H., Page, K. R., Dacke, C. G., Abramovich, D. R. et al., Evidence of saturable uptake mechanisms at maternal and fetal sides of the perfused human placenta by rapid paired-tracer dilution: studies with calcium and choline. J. Dev. Physiol. 1986, 8, 435-445.
37. Blusztajn, J. K., Mellott, T. J., Choline nutrition programs brain development via DNA and histone methylation. Cent. Nerv. Syst. Agents Med. Chem. 2012, 12, 82-94
38. Li, Z., Agellon, L. B., Vance, D. E., Choline redistribution during adaptation to choline deprivation. J. Biol. Chem. 2007, 282, 10283-10289.
39. Devlin, A., Arning, E., Bottiglieri, T., Faraci, F. et al., Effect of Mthfr genotype on diet-induced hyperhomocysteinemia and vascular function in mice. Blood 2004, 103, 2624-2629.
40. Caudill, M. A., Wang, J. C., Melnyk, S., Pogribny, I. P. et al., Intracellular S-adenosylhomocysteine concentrations predict global DNA hypomethylation in tissues of methyl-deficient cystathionine beta-synthase heterozygous mice. J. Nutr. 2001, 131, 2811-2818.
41. Mikael, L. G., Rozen, R., Homocysteine modulates the effect of simvastatin on expression of ApoA-I and NF-kB/iNOS. Cardiovasc. Res. 2008, 80, 151-158.
42. Mc Lean, J. M., Mosley, J. G., Gibbs, A. C. C., Changes in the thymus, spleen and lymph nodes during pregnancy and lactation in the rat. J. Anat. 1974, 118, 223-229.
43. Challis, J. R., Lockwood, C. J., Myatt, L., Norman, J. E. et al., Inflammation and pregnancy. Reprod. Sci. 2009, 16, 206-215.
44. De Lemos, M. A., How your mother tolerated you for nine months. BioTeach J. 2003, 1, 27-29.
45. Szekeres-Bartho, J., Halasz, M., Palkovics, T., Progesterone in pregnancy; receptor-ligand interaction and signaling pathways. J. Reprod. Immunol. 2009, 83, 60-64.
46. Banerjee, S., Smallwood, A., Moorhead, J., Chambers, A. E. et al., Placental expression of interferon-γ (IFN-γ) and its receptor IFN-γR2 fail to switch from early hypoxic to late normotensive development in preeclampsia. J. Clin. Endocrinol Metab. 2005, 90, 944-952.
47. Furlaneto, C. J., Ribeiro, F. P., Hatanaka, E., Souza, G. M. et al., Apolipoproteins A-I and A-II downregulate neutrophil functions. Lipids 2002, 37, 925-928.
48. Costantini, C., Calzetti, F., Perbellini, O., Micheletti, A. et al., Human neutrophils interact with both 6-sulfo LacNAc +DC and NK cells to amplify NK-derived IFNg: role of CD18, ICAM-1 and ICAM-3. Blood 2011, 117, 1677-1686.
49. Landreth, K. S., Critical windows in development of the rodent immune system. Hum. Exp. Toxicol. 2002, 21, 493-498.
50. Hardardóttir, I., Moser, A. H., Memon, R., Grünfeld, C. et al., Effects of TNF, IL-1, and the combination of both cytokines on cholesterol metabolism in Syrian hamsters. Lymphokine Cytokine Res. 1994, 13, 161-166.
51. Haas, M. J., Horani, M., Mreyoud, A., Plummer, B. et al., Suppression of apolipoprotein AI gene expression in HepG2 cells by TNF alpha and IL-1beta. Biochim. Biophys. Acta 2003, 1623, 120-128.
52. Jawerbaum, A., Capobianco, E., Review: effects of PPAR activation in the placenta and the fetus: implications in maternal diabetes. Placenta 2011, 32, S212-S217.
53. Thompson, P. W., Bayliffe, A. I., Warren, A. P., Lamb, J. R., Interleukin-10 is upregulated by nanomolar rosiglitazone treatment of mature dendritic cells and human CD4+ T cells. Cytokine 2007, 39, 184-191.
54. Dong, M., He, J., Wang, Z., Xie, X. et al., Placental imbalance of Th1- and Th2-type cytokines in preeclampsia. Acta. Obstet. Gynecol. Scand. 2005, 84, 788-793.
55. Yessoufou, A., Hichami, A., Besnard, P., Moutairou, K., et al., Peroxisome proliferator-acvtivated receptor α deficiency increases the risk of maternal abortion and neonatal mortality in murine pregnancy with or without diabetes mellitus: modulation of T cell differentiation. Endocrinology 2006, 147, 4410-4418.
56. Kalkunte, S., Nevers, T., Norris, W. E., Sharma, S., Vascular IL-10: a protective role in preeclampsia. J. Reprod. Immunol. 2011, 88, 165-169.
57. Schroecksnadel, K., Frick, B., Winkler, C., Fuchs, D., Crucial role of interferon-gamma and stimulated macrophages in cardiovascular disease. Curr. Vasc. Pharmacol. 2006, 4, 205-213.
58. Schroecksnadel, K., Frick, B., Wirleitner, B., Winkler, C. et al., Moderate hyperhomocysteinemia and immune activation. Curr. Pharm. Biotechnol. 2004, 5, 107-118.
59. Wu, J. T., Circulating homocysteine is an inflammation marker and a risk factor of life-threatening inflammatory diseases. J. Biomed. Lab Sci. 2007, 19, 107-111.
60. Yu, S., Reddy, J. K., Transcription coactivators for peroxisome proliferator-activated receptors. Biochim. Biophys. Acta 2007, 1771, 936-951.
61. Harnish, D. C., Malik, S., Kilbourne, E., Costa, R. et al., Control of apolipoprotein AI gene expression through synergistic interactions between hepatocyte nuclear factors 3 and 4. J. Biol. Chem. 1996, 271, 13621-13628.
62. Kim, Y. I., Miller, J. W., da Costa, K. A., Nadeau, M. et al., Severe folate deficiency causes secondary depletion of choline and phosphocholine in rat liver. J. Nutr. 1994, 124, 2197-2203.
63. Varela-Moreiras, G., Selhub, J., da Costa, K.-A., Zeisel, S. H., Effect of chronic choline deficiency in rats on liver folate content and distribution. J. Nutr. Biochem. 1992, 3, 519-522.